Genocea Biosciences (GNCA) Misses Q1 EPS by 11c

Genocea Biosciences (NASDAQ: GNCA) reported Q1 EPS of ($0.46), $0.11 worse than the analyst estimate of ($0.35).

Genocea expects that its existing cash and cash equivalents are sufficient to support its operations into the first quarter of 2021.

For earnings history and earnings-related data on Genocea Biosciences (GNCA) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Boost Run, Inc. (BRUN) Reports Q2 Revenue of $31.1M
• Zeo Energy Corp (ZEO) Misses Q2 EPS by 7c